EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides

Melisa Gualdrón-López, Alberto Ayllon-Hermida, Núria Cortes-Serra, Patricia Resa-Infante, Joan Josep Bech-Serra, Iris Aparici-Herraiz, Marc Nicolau-Fernandez, Itziar Erkizia, Lucia Gutierrez-Chamorro, Silvia Marfil, Edwards Pradenas, Carlos Ávila Nieto und 18 weitere

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1442743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Melisa Gualdrón-López und 29 weiteren Autor:innen. Beteiligte Einrichtung: ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Extracellular Vesicles, COVID-19, Proteomics, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) released by virus-infected cells have the potential to encapsulate viral peptides, a characteristic that could facilitate vaccine development. Furthermore, plasma-derived EVs may elucidate pathological changes occurring in distal tissues during viral infections. We hypothesized that molecular characterization of EVs isolated from COVID-19 patients would reveal peptides suitable for vaccine development. Blood samples were collected from three cohorts: severe COVID-19 patients (G1), mild/asymptomatic cases (G2), and SARS-CoV-2-negative healthcare workers (G3). Samples were obtained at two time points: during the initial phase of the pandemic in early 2020 (m0) and eight months later (m8). Clinical data analysis revealed elevated inflammatory markers in G1. Notably, non-vaccinated individuals in G1 exhibited increased levels of neutralizing antibodies at m8, suggesting prolonged exposure to viral antigens. Proteomic profiling of EVs was performed using three distinct methods: immunocapture (targeting CD9), ganglioside-capture (utilizing Siglec-1) and size-exclusion chromatography (SEC). Contrary to our hypothesis, this analysis failed to identify viral peptides. These findings were subsequently validated through Western blot analysis targeting the RBD of the SARS-CoV-2 Spike protein’s and comparative studies using samples from experimentally infected Syrian hamsters. Furthermore, analysis of the EV cargo revealed a diverse molecular profile, including components involved in the regulation of viral replication, systemic inflammation, antigen presentation, and stress responses. These findings underscore the potential significance of EVs in the pathogenesis and progression of COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesCOVID-19ProteomicsSARS-CoV-2AnimalsHumansMaleAntibodies, NeutralizingFemalePeptidesAntibodies, ViralMesocricetusAdultMiddle AgedCricetinaeViral Proteins

Stichwörter der Autor:innen

COVID-19 patientsSARS-CoV-2antibody responseextracellular vesiclesganglioside-capture (CD169/Siglec-1)immunocapture (CD9)proteomics profilingsize-exclusion chromatography (SEC)

Substanzen

Antibodies, NeutralizingPeptidesAntibodies, ViralViral Proteins

Autor:innen und Institutionen

  • ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
  • Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.
  • IrsiCaixa, Badalona, Spain.
  • CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
  • University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.
  • Josep Carreras Leukemia Research Institute, Badalona, Spain.

Zitieren

APA

Gualdrón-López, M., Ayllon-Hermida, A., Cortes-Serra, N., Resa-Infante, P., Bech-Serra, J. J., Aparici-Herraiz, I., Nicolau-Fernandez, M., Erkizia, I., Gutierrez-Chamorro, L., Marfil, S., Pradenas, E., Ávila Nieto, C., Cucurull, B., Montaner-Tarbés, S., Muelas, M., Sotil, R., Ballana, E., Urrea, V., Fraile, L., …, & Del Portillo, H. A. (2024). Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1442743

Vancouver

Gualdrón-López M, Ayllon-Hermida A, Cortes-Serra N, Resa-Infante P, Bech-Serra JJ, Aparici-Herraiz I, et al. Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1442743

BibTeX
@article{GualdrnLpez2024,
  author = {Gualdrón-López, Melisa and Ayllon-Hermida, Alberto and Cortes-Serra, Núria and Resa-Infante, Patricia and Bech-Serra, Joan Josep and Aparici-Herraiz, Iris and Nicolau-Fernandez, Marc and Erkizia, Itziar and Gutierrez-Chamorro, Lucia and Marfil, Silvia and Pradenas, Edwards and Ávila Nieto, Carlos and Cucurull, Bernat and Montaner-Tarbés, Sergio and Muelas, Magdalena and Sotil, Ruth and Ballana, Ester and Urrea, Victor and Fraile, Lorenzo and Montoya, Maria and Vergara, Julia and Segales, Joaquim and Carrillo, Jorge and Izquierdo-Useros, Nuria and Blanco, Julià and Fernandez-Becerra, Carmen and de La Torre, Carolina and Pinazo, Maria-Jesus and Martinez-Picado, Javier and Del Portillo, Hernando A},
  title = {Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1442743}
}
Kostenlos starten →